Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents.

ABSTRACT: Gastric cancer is the second most common cause of cancer death worldwide. Recent development of targeted agents provides clinicians with additional systemic treatment options to conventional cytotoxic agents. Predictive markers are undoubtedly important for guiding the appropriate use of targeted and cytotoxic agents. Currently, however, HER2 is the only predictive biomarker validated for gastric cancer. In this review, candidate predictive markers for response to other targeted agents and cytotoxic chemotherapeutic agents are discussed.

SUBMITTER: Kim HK 

PROVIDER: S-EPMC7670597 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature